Terry J. Rosen, Chief Executive Officer at Arcus Biosciences, Inc. (RCUS), sold 26,086 shares at $30.66 ($802K) on 2022-12-16, disclosed to the SEC on 2022-12-16.
Open-market sale of $802k RCUS by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.66 | 10,983 | $337K | 42.0% |
| 2 | $30.66 | 10,983 | $337K | 42.0% |
| 3 | $31.23 | 2,060 | $64K | 8.0% |
| 4 | $31.23 | 2,060 | $64K | 8.0% |
| Total | $30.75 avg | 26,086 | $802K | 100% |
| Filing → |
| RCUS | SELL | 2022-06-21 | $350K | — | Filing → |
| RCUS | SELL | 2021-12-20 | $277K | — | Filing → |
| RCUS | SELL | 2021-06-21 | $418K | — | Filing → |